Tyche Industries
106.15
-4.30(-3.89%)
Market Cap₹108.79 Cr
PE Ratio16.84
IndustryHealthcare
Company Performance:
1D-3.89%
1M+0.66%
6M-22.74%
1Y-20.19%
5Y-49.91%
View Company Insightsright
More news about Tyche Industries
14Aug 25
Tyche Industries Reports 9% Revenue Growth Amid Profit Decline in Q1 FY2026
Tyche Industries Limited, an API manufacturer, released Q1 FY2026 results. Total income increased 9% to ₹1,269.99 lakhs, but net profit fell 11% to ₹243.15 lakhs. EPS decreased from ₹2.66 to ₹2.37. Export sales dominated at ₹1,261.52 lakhs, over 99% of total sales. Net profit margin declined from 23.4% to 19.1%. The Board approved these results on August 12, 2025.
 no imag found
Tyche Industries
106.15
-4.30
(-3.89%)
1 Year Returns:-20.19%
Industry Peers
Sun Pharmaceutical
1,750.50
(-0.11%)
Divis Laboratories
6,316.00
(-1.37%)
Torrent Pharmaceuticals
4,341.00
(-0.65%)
Dr Reddys Laboratories
1,291.20
(-0.25%)
Cipla
1,313.20
(-2.84%)
Lupin
2,304.90
(-0.27%)
Mankind Pharma
2,207.20
(-1.71%)
Zydus Life Science
896.90
(-1.10%)
Aurobindo Pharma
1,195.40
(-1.24%)
Alkem Laboratories
5,466.50
(-1.79%)